30/10/2024
Exciting news! Our latest review article, “SGLT2 Inhibitors: Exploring the Effects in Humans and Horses,” has just been published in Equine Veterinary Education.
This global collaborative effort brought together my co-authors who are experts in human and equine medicine, as well as equine nutrition, to explore the use of SGLT2 inhibitors—such as ertugliflozin, canagliflozin, and dapagliflozin—in both species. While these medications have been extensively researched and used in human healthcare for nearly a decade, their application in horses is still evolving.
In the article, we highlight both the therapeutic potential and the possible side effects of these drugs in horses. Drawing from human medicine, where SGLT2 inhibitors have shown significant benefits for managing diabetes and cardiovascular disease, we also discuss how these lessons might help us mitigate risks and optimize their use in equine medicine.
https://beva.onlinelibrary.wiley.com/doi/full/10.1111/eve.14071
🩺 Contact us on 0427 072 095 or book an appointment online: https://avonridgeequine.com.au/book-an-appointment/